trastuzumab deruxtecan
astrazeneca,daiichi sankyo
['trastuzumab', 'breast']
trastuzumab deruxtecan in previously treated her2-low advanced breast cancer | #asco22 
The official account of Memorial Sloan Kettering Cancer Center, the Sloan Kettering Institute, and Louis V. Gerstner, Jr. Graduate School of Biomedical Sciences